These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28757310)

  • 41. Assessment of Learning, Memory, and Attention in Developmental Neurotoxicology Regulatory Testing: Commentary on essentiality of cognitive assessment for protecting child health.
    Vorhees CV
    Neurotoxicol Teratol; 2017 May; 61():135-137. PubMed ID: 28109771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current status of developmental neurotoxicity: regulatory view.
    Hass U
    Toxicol Lett; 2003 Apr; 140-141():155-9. PubMed ID: 12676462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing.
    Serafini MM; Sepehri S; Midali M; Stinckens M; Biesiekierska M; Wolniakowska A; Gatzios A; Rundén-Pran E; Reszka E; Marinovich M; Vanhaecke T; Roszak J; Viviani B; SenGupta T
    Arch Toxicol; 2024 May; 98(5):1271-1295. PubMed ID: 38480536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
    Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
    ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compilation of international regulatory guidance documents for neuropathology assessment during nonclinical general toxicity and specialized neurotoxicity studies.
    Bolon B; Bradley A; Butt M; Jensen K; Krinke G; Mellon RD
    Toxicol Pathol; 2011 Jan; 39(1):92-6. PubMed ID: 21119055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.
    Bogdanffy MS; Daston G; Faustman EM; Kimmel CA; Kimmel GL; Seed J; Vu V
    Toxicol Sci; 2001 May; 61(1):18-31. PubMed ID: 11294970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutual acceptance of data: harmonised test methods and quality assurance of data--the process explained.
    Koëter HB
    Toxicol Lett; 2003 Apr; 140-141():11-20. PubMed ID: 12676446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.
    Carlson LM; Champagne FA; Cory-Slechta DA; Dishaw L; Faustman E; Mundy W; Segal D; Sobin C; Starkey C; Taylor M; Makris SL; Kraft A
    Neurotoxicol Teratol; 2020; 78():106865. PubMed ID: 32068112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test).
    Reuter U; Heinrich-Hirsch B; Hellwig J; Holzum B; Welsch F
    Regul Toxicol Pharmacol; 2003 Aug; 38(1):17-26. PubMed ID: 12878050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developmental toxicity, reproductive toxicity, and neurotoxicity as regulatory endpoints.
    McMaster SB
    Toxicol Lett; 1993 May; 68(1-2):225-30. PubMed ID: 8516767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Best practices for developmental toxicity assessment for classification and labeling.
    Daston G; Piersma A; Attias L; Beekhuijzen M; Chen C; Foreman J; Hallmark N; Leconte I
    Reprod Toxicol; 2018 Sep; 80():44-48. PubMed ID: 29753929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations.
    Sachana M; Shafer TJ; Terron A
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
    Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
    Hass U
    Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes.
    Fritsche E; Crofton KM; Hernandez AF; Hougaard Bennekou S; Leist M; Bal-Price A; Reaves E; Wilks MF; Terron A; Solecki R; Sachana M; Gourmelon A
    ALTEX; 2017; 34(2):311-315. PubMed ID: 28407175
    [No Abstract]   [Full Text] [Related]  

  • 57. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.
    Crofton KM; Makris SL; Sette WF; Mendez E; Raffaele KC
    Neurotoxicol Teratol; 2004; 26(3):345-52. PubMed ID: 15113596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current activities between the DevTox Berlin workshops and the Japanese Teratology Society Terminology Committee in harmonizing the terminology for classifying anomalies in laboratory animals in developmental toxicity studies: Report from the Satellite Workshop of the 60th Annual Meeting of the Japanese Teratology Society.
    Kuwagata M; Sato A; Izumi Y; Chihara K; Yamasaki H; Katsumata Y; Ooshima Y; Buschmann J; Fujiwara M
    Congenit Anom (Kyoto); 2022 Sep; 62(5):198-202. PubMed ID: 35665967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
    Aschner M; Ceccatelli S; Daneshian M; Fritsche E; Hasiwa N; Hartung T; Hogberg HT; Leist M; Li A; Mundi WR; Padilla S; Piersma AH; Bal-Price A; Seiler A; Westerink RH; Zimmer B; Lein PJ
    ALTEX; 2017; 34(1):49-74. PubMed ID: 27452664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research.
    Embry MR; Belanger SE; Braunbeck TA; Galay-Burgos M; Halder M; Hinton DE; Léonard MA; Lillicrap A; Norberg-King T; Whale G
    Aquat Toxicol; 2010 Apr; 97(2):79-87. PubMed ID: 20061034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.